Growth Metrics

Bionano Genomics (BNGO) Non-Current Assets (2017 - 2025)

Bionano Genomics (BNGO) has disclosed Non-Current Assets for 9 consecutive years, with $28.2 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 24.16% to $28.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $125.3 million through Dec 2025, down 42.72% year-over-year, with the annual reading at $28.2 million for FY2025, 24.16% down from the prior year.
  • Non-Current Assets hit $28.2 million in Q4 2025 for Bionano Genomics, down from $30.3 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $150.2 million in Q4 2022 to a low of $14.6 million in Q1 2021.
  • Historically, Non-Current Assets has averaged $70.6 million across 5 years, with a median of $70.6 million in 2024.
  • Biggest five-year swings in Non-Current Assets: skyrocketed 666.31% in 2021 and later tumbled 53.77% in 2024.
  • Year by year, Non-Current Assets stood at $104.7 million in 2021, then skyrocketed by 43.48% to $150.2 million in 2022, then crashed by 50.54% to $74.3 million in 2023, then plummeted by 49.95% to $37.2 million in 2024, then fell by 24.16% to $28.2 million in 2025.
  • Business Quant data shows Non-Current Assets for BNGO at $28.2 million in Q4 2025, $30.3 million in Q3 2025, and $33.3 million in Q2 2025.